MeSH D013922 - thrombocytosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Allergan | Anagrelide | Anagrelide | 2005-04-18 | |||
| Barr Pharmaceuticals | Anagrelide | Anagrelide | 2005-04-18 | |||
| Chartwell Pharmaceuticals | Anagrelide | Anagrelide | 2005-04-18 | |||
| Impax Laboratories | Anagrelide | Anagrelide | 2005-04-18 | |||
| Mylan | Anagrelide | Anagrelide Mylan | 2018-02-15 | |||
| NATCO Pharma | Anagrelide | Anagrelide | 2005-04-18 | |||
| Rising Pharmaceuticals | Anagrelide | Anagrelide | 2006-06-27 | |||
| Roxane Laboratories | Anagrelide | Anagrelide | 2005-04-18 | |||
| Takeda | Anagrelide | Agrylin | 1997-03-14 | |||
| Anagrelide | Xagrid | 2004-11-15 |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
10%6/58
Phase 2
0%0/15
Phase 3
100%3/3
Approved: 3Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use